Taro Pharmaceutical Industries Ltd (TARO)
42.21
-0.02
(-0.05%)
USD |
NYSE |
Apr 24, 16:00
42.21
0.00 (0.00%)
After-Hours: 20:00
Taro Pharmaceutical Industries Gross Profit (Quarterly): 79.88M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 79.88M |
September 30, 2023 | 73.60M |
June 30, 2023 | 64.08M |
March 31, 2023 | 75.71M |
December 31, 2022 | 64.05M |
September 30, 2022 | 46.96M |
June 30, 2022 | 81.61M |
March 31, 2022 | 77.34M |
December 31, 2021 | 76.03M |
September 30, 2021 | 62.04M |
June 30, 2021 | 77.70M |
March 31, 2021 | 76.93M |
December 31, 2020 | 73.19M |
September 30, 2020 | 81.59M |
June 30, 2020 | 64.95M |
March 31, 2020 | 102.27M |
December 31, 2019 | 94.13M |
September 30, 2019 | 101.60M |
June 30, 2019 | 101.72M |
March 31, 2019 | 119.54M |
December 31, 2018 | 117.54M |
September 30, 2018 | 108.56M |
June 30, 2018 | 100.08M |
March 31, 2018 | 118.93M |
December 31, 2017 | 102.92M |
Date | Value |
---|---|
September 30, 2017 | 125.12M |
June 30, 2017 | 116.54M |
March 31, 2017 | 143.83M |
December 31, 2016 | 167.34M |
September 30, 2016 | 177.29M |
June 30, 2016 | 182.79M |
March 31, 2016 | 224.23M |
December 31, 2015 | 214.18M |
September 30, 2015 | 168.76M |
June 30, 2015 | 171.80M |
March 31, 2015 | 199.64M |
December 31, 2014 | 193.49M |
September 30, 2014 | 198.09M |
June 30, 2014 | 85.37M |
March 31, 2014 | 141.36M |
December 31, 2013 | 172.46M |
September 30, 2013 | 159.47M |
June 30, 2013 | 106.72M |
March 31, 2013 | 119.48M |
December 31, 2012 | 139.93M |
September 30, 2012 | 121.33M |
June 30, 2012 | 114.10M |
March 31, 2012 | 99.17M |
December 31, 2011 | 106.05M |
September 30, 2011 | 93.31M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
46.96M
Minimum
Sep 2022
102.27M
Maximum
Mar 2020
77.65M
Average
76.93M
Median
Mar 2021
Gross Profit (Quarterly) Benchmarks
InspireMD Inc | 0.505M |
Ayala Pharmaceuticals Inc | 0.00 |
BiomX Inc | -- |
Alpha Tau Medical Ltd | -- |
Pluri Inc | -- |